

(Sharecast News) - AstraZeneca announced on Thursday that 'Tagrisso', or osimertinib, has been approved by the US Food and Drug Administration (FDA) f...


(Alliance News) - A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at th...


FTSE 100 up 0.4%, FTSE 250 adds 0.1% *


(Sharecast News) - London's stock markets ended Monday on a positive note, as investors pored over a number of economic activity reports from both the...


(Alliance News) - AstraZeneca PLC on Monday said a breast cancer drug failed to significantly extend patients' lives, a second blow this month to hope...


(Alliance News) - Stocks in London are to open higher on Monday, ahead of flash composite purchasing managers' index data from the US, the UK and main...


(Sharecast News) - AstraZeneca updated the market on two ongoing drug trials on Monday, with a key trial in breast cancer failing to improve survival.